Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

This grant funds research on early immune system development in neonates, infants, children, and adolescents, especially in the context of HIV, anti-retroviral exposure, maternal and paternal immune status, and related factors such as the microbiome, co-infections, diet, metabolism, and obesity. Eligible applicants include a wide range of U.S. and non-U.S. organizations, including nonprofits, universities, governments, for-profit organizations, and foreign organizations. Application budgets are limited to $400,000 per year in direct costs, excluding consortium F&A costs, and the project period can be up to four years. No cost sharing is required, and foreign components and non-domestic entities are allowed.

✳ AI-generated summary — verify against the announcement

• Health
• Income Security and Social Services
• Research & Discovery
• Children, Youth & Families
• Patients & People with Health Conditions
• Biomedical & Disease Research

• ✓ City or township governments
• ✓ County governments
• ✓ For-profit organizations other than small businesses
• ✓ Independent school districts
• ✓ Native American tribal governments (Federally recognized)
• ✓ Native American tribal organizations (other than Federally recognized)
• ✓ Nonprofits with 501(c)(3) status (other than higher education)
• ✓ Nonprofits without 501(c)(3) status (other than higher education)
• ✓ Others
• ✓ Private institutions of higher education
• ✓ Public and State controlled institutions of higher education
• ✓ Public housing authorities / Indian housing authorities
• ✓ Small businesses
• ✓ Special district governments
• ✓ State governments